Rezolute, Inc. (RZLT) NASDAQ
Currency In USD
- General
- Statistics
- Historical Data
- Profile
- Financials
Rezolute, Inc.
Address
275 Shoreline Drive
Redwood City, CA 94065
United States of America (the)
Phone
650 206 4507
Website
Sector
Healthcare
Industry
Biotechnology
Employees
71
First IPO Date
January 14, 2013
Key Executives
| Name | Title | Pay | Year Born |
| Nevan Charles Elam | Founder, Chief Executive Officer, Principal Financial Officer & Acting Chairman of the Board | 1.08M | 1967 |
| Daron G. Evans | Chief Financial & Business Officer | 699,209 | 1974 |
| Brian Kenneth Roberts | Chief Medical Officer | 767,526 | 1976 |
| Chris Milks | Vice President & Head of Finance | 0 | N/A |
| Robyn Sweinhart | Vice President & Head of Quality | 0 | N/A |
| Raj Agrawal | Vice President & Head of Ophthalmological Clinical Development | 0 | N/A |
| Melissa Quinn | Senior Director of People and Culture | 0 | N/A |
| Davelyn Eaves Hood | Director and Head of Scientific & Patient Affairs | 0 | N/A |
| Michael Covarrubias | Senior Vice President & Head of Program & Portfolio Management | 0 | N/A |
| Michael R. Deperro | Senior VP & Head of Operations | 0 | N/A |
Description
Rezolute, Inc., a late-stage rare disease company, focused on improving outcomes for individuals with hypoglycemia caused by hyperinsulinism in the United States. Its lead clinical asset is ersodetug, an intravenously administered human monoclonal antibody that is in Phase 3 clinical trial for the treatment of congenital hyperinsulinism, an ultra-rare pediatric genetic disorder, as well as for the treatment of hypoglycemia; and clinical trials of ersodetug for tumor hyperinsulinism. The company was formerly known as AntriaBio, Inc. and changed its name to Rezolute, Inc. in December 2017. Rezolute, Inc. was founded in 2010 and is headquartered in Redwood City, California.
